Jennison Associates
KITE

Jennison Associates’s Kite Pharma, Inc. KITE Stock Holding History

Jennison Associates’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-260,593
Closed -$27M – 718
2017
Q2 		$27M Sell
260,593
-362,014
-58% -$29.5M 0.03% 359
2017
Q1 		$48.9M Hold
622,607
– – 0.05% 269
2016
Q4 		$27.9M Buy
622,607
+507,728
+442% +$24.9M 0.03% 364
2016
Q3 		$6.42M Buy
+114,879
New +$6.4M 0.01% 498
2015
Q1 		– Sell
-77,821
Closed -$4.49M – 777
2014
Q4 		$4.49M Sell
77,821
-84
-0.1% -$3.54K ﹤0.01% 515
2014
Q3 		$2.22M Buy
+77,905
New +$1.93M ﹤0.01% 572

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates's KITE Position: Q3 2017 in Review

Jennison Associates sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 260,593 shares — an estimated $27M sold.

Jennison Associates first reported a position in KITE in Q3 2014 and held it in 6 quarters. The position peaked at $48.9M in Q1 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Jennison Associates reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Jennison Associates sold 260,593 Kite Pharma, Inc. shares in Q3 2017, an estimated $27M.
  • Jennison Associates first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 6 quarters.
  • Jennison Associates's Kite Pharma, Inc. position peaked at $48.9M in Q1 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Jennison Associates's 13F filing for Q3 2017, filed 3 Nov 2017.